SEQENS is an integrated global leader in pharmaceutical solutions and specialty ingredients, delivering unrivalled market responsiveness and tailor-made solutions to our customers.

SEQENS operates 24 manufacturing plants and 3 R&D centers in Europe, North America and Asia with 3,200 employees. More than 300 scientists, engineers and experts develop tailor-made solutions for our customers and ensure that products are successfully transferred into production.